Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Historia
454
Condiciones sociales
86
Condiciones económicas
85
Desarrollo de recursos hídricos
80
Política y gobierno
69
Indígenas de México
65
Aspectos sociales
62
Vida social y costumbres
60
Abastecimiento de agua
54
Novela española
54
Leyes y legislación
49
Crítica e interpretación
45
Historia y crítica
44
Educación
35
Cuentos uruguayos
34
Estudio y enseñanza
31
Filosofía
30
Aspectos económicos
29
Antigüedades
26
Administración municipal
24
Administración
23
Biografías
23
Otomíes
20
Descripciones y viajes
19
México
19
Política gubernamental
19
Agricultura
18
Aspectos políticos
18
Diagnóstico
18
Fuentes
18
-
8921por Rodden, Layne N., Gilliam, Kaitlyn M., Lam, Christina, Lynch, David R., Bidichandani, Sanjay I.“…A class I histone deacetylase inhibitor (HDACi-109) reactivates the silenced FXN gene, although with considerable inter-individual variability, which remains etiologically unexplained. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8922por Angiolilli, Chiara, Kabala, Pawel A, Grabiec, Aleksander M, Van Baarsen, Iris M, Ferguson, Bradley S, García, Samuel, Malvar Fernandez, Beatriz, McKinsey, Timothy A, Tak, Paul P, Fossati, Gianluca, Mascagni, Paolo, Baeten, Dominique L, Reedquist, Kris A“…OBJECTIVES: Non-selective histone deacetylase (HDAC) inhibitors (HDACi) have demonstrated anti-inflammatory properties in both in vitro and in vivo models of rheumatoid arthritis (RA). …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8923por Anderson, Letícia, Gomes, Monete Rajão, daSilva, Lucas Ferreira, Pereira, Adriana da Silva Andrade, Mourão, Marina M., Romier, Christophe, Pierce, Raymond, Verjovski-Almeida, Sergio“…We investigated the effect of TSA HDACi on schistosomula gene expression at three different time points, finding a marked genome-wide change in the transcriptome profile. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8924por Avallone, Antonio, Piccirillo, Maria Carmela, Di Gennaro, Elena, Romano, Carmela, Calabrese, Filomena, Roca, Maria Serena, Tatangelo, Fabiana, Granata, Vincenza, Cassata, Antonio, Cavalcanti, Ernesta, Maurea, Nicola, Maiolino, Piera, Silvestro, Lucrezia, De Stefano, Alfonso, Giuliani, Francesco, Rosati, Gerardo, Tamburini, Emiliano, Aprea, Pasquale, Vicario, Valeria, Nappi, Anna, Vitagliano, Carlo, Casaretti, Rossana, Leone, Alessandra, Petrillo, Antonella, Botti, Gerardo, Delrio, Paolo, Izzo, Francesco, Perrone, Francesco, Budillon, Alfredo“…Histone-deacetylase inhibitors (HDACi) have shown activity in combination with chemotherapy in the treatment of solid tumors. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8925“…In this study, we sought to determine the mechanisms contributing to reduced levels of miRNAs, as well as how HDACi restores the levels of reduced miRNA in PH vascular cells. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8926por Du, Li, Wang, Dongyuan, Wei, Xiuqi, Liu, Chang, Xiao, Zhuanglong, Qian, Wei, Song, Yuhu, Hou, Xiaohua“…METHODS: In this report, we tested the therapeutic effect of different isoform selective HDAC inhibitors (Class I HDACI MS275, Class IIa HDACI MC1568, pan-HDAC inhibitors SAHA) on malignant ascites in vitro and in vivo. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8927“…Accordingly, several drugs targeting the epigenome have been proposed for cancer therapy, notably, histone deacetylase inhibitors (HDACi) such as Vorinostatis and DNA methyltransferase inhibitors (DNMTi) such as Zebularine. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8928por Hennig, D, Müller, S, Wichmann, C, Drube, S, Pietschmann, K, Pelzl, L, Grez, M, Bug, G, Heinzel, T, Krämer, O H“…Thus, BCL-xL and C/EBPɛ are newly identified molecular markers for the efficacy of HDACi against APL cells. CONCLUSIONS: Our results could explain the therapeutic limitations occurring with ATRA and class I HDACi combinations. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8929“…Conclusions: These results indicate that HDACi attenuates the transcriptional activity of FoxO1 by impeding deacetylation, thereby ameliorating hyperglycemia in T2DM rats.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8930por Yang, Yang, Yan, Yu, Chen, Zhen, Hu, Jie, Wang, Kai, Tang, Ni, Li, Xiaosong, Zhou, Zhi“…Romidepsin (FK228) and vorinostat (SAHA) are histone deacetylase inhibitors (HDACi) approved by the Food and Drug Administration as novel antitumor agents. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8931por Chong, Wai C., Jayasekara, W. Samantha N., Vaghjiani, Vijesh G., Parackal, Sarah, Sun, Claire, Popovski, Dean, Algar, Elizabeth M., Firestein, Ron, Wood, Paul J., Khan, Sara, Huang, Annie, Ashley, David M., Downie, Peter, Cain, Jason E.“…However, the potential efficacy of HDACi in ATRT is unknown. Here, we show that human ATRT cells are highly responsive to the HDACi panobinostat and that sustained treatment leads to growth arrest, increased cell senescence, decreased clonogenicity and induction of a neurogenesis gene-expression profile. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8932por Shim, Seon-Hui, Tufa, Dejene, Woods, Renee, George, Trahan D, Shank, Tyler, Yingst, Ashley, Lake, Jessica, Cobb, Laura, Jones, Dallas, Jones, Kenneth, Verneris, Michael R“…Pluripotent stem cells cultured in the presence of HDACi showed a 2-5 times increase in HSPCs. Concurrent with this, HDACi-treated PSCs increased expression of 7 transcription factors (HOXA5, HOXA9, HOXA10, RUNX1, ERG, SPI1, and LCOR) recently shown to convert HE to HSPCs. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8933por Rivera-Del Valle, Nilsa, Gao, Shan, Miller, Claudia P., Fulbright, Joy, Gonzales, Carolina, Sirisawad, Mint, Steggerda, Susanne, Wheler, Jennifer, Balasubramanian, Sriram, Chandra, Joya“…Histone deacetylase inhibitors (HDACi) have become a promising new avenue for cancer therapy, and many are currently in Phase I/II clinical trials for various tumor types. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
8934por Merarchi, Myriam, Sethi, Gautam, Shanmugam, Muthu K., Fan, Lu, Arfuso, Frank, Ahn, Kwang Seok“…Hence, the discovery and development of novel HDACi from natural products, which are known to affect the activation of various oncogenic molecules, has attracted significant attention over the last decade. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8935por Duan, Yueyue, Cao, Liyan, Yuan, Cong, Suo, Xuepeng, Kong, Xiangyu, Gao, Yulong, Li, Xiangtong, Zheng, Haixue, Wang, Xiaomei, Wang, Qi“…Moreover, we collected samples in ALV-infected chickens and found that the acetylation status of ALV-bound H3 and H4 histones correlated with ALV viremia. HDAC inhibitors (HDACi) potently increase ALV replication, but HDACi-promoted viral replication is dramatically reduced in cells with p53 depletion. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8936por Chiu, Hui-Wen, Yeh, Ya-Ling, Wang, Yi-Ching, Huang, Wei-Jan, Ho, Sheng-Yow, Lin, Pinpin, Wang, Ying-Jan“…Histone deacetylase inhibitors (HDACi) are a group of targeted anticancer agents that enhance radiosensitivity. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8937por de Pádua Covas Lage, Luís Alberto, Araújo Soares, Vinícius, Meneguin, Thales Dalessandro, Culler, Hebert Fabrício, Reichert, Cadiele Oliana, Jacomassi, Mayara D’Auria, Reis, Diego Gomes Cândido, Zerbini, Maria Cláudia Nogueira, de Oliveira Costa, Renata, Rocha, Vanderson, Pereira, Juliana“…Among 40 patients treated with HD-MTX-based induction, estimated 2-year OS was 85.8% for those consolidated with WBRT plus HIDAC versus only 41.5% for those consolidated with HIDAC alone (p < 0.001). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8938por Daniel, Kevin B., Sullivan, Eric D., Chen, Yao, Chan, Joshua C., Jennings, Patricia A., Fierke, Carol A., Cohen, Seth M.“…[Image: see text] Histone deacetylase inhibitors (HDACi) target abnormal epigenetic states associated with a variety of pathologies, including cancer. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8939por Zhu, Xiaoyu, Liu, Xin, Cheng, Zhongyi, Zhu, Jun, Xu, Lei, Wang, Fengsong, Qi, Wulin, Yan, Jiawei, Liu, Ning, Sun, Zimin, Liu, Huilan, Peng, Xiaojun, Hao, Yingchan, Zheng, Nan, Wu, Quan“…Valproic acid (VPA) and suberoylanilide hydroxamic acid (SAHA) are both HDAC inhibitors (HDACi). Previous studies indicated that both inhibitors show therapeutic effects on acute myeloid leukaemia (AML), while the differential impacts of the two different HDACi on AML treatment still remains elusive. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8940por Gray, L R, Cowley, D, Welsh, C, Lu, H K, Brew, B J, Lewin, S R, Wesselingh, S L, Gorry, P R, Churchill, M J“…Latency-reversing agents (LRAs), including histone deacetylase inhibitors (HDACi), are being investigated as a strategy to eliminate latency in HIV-infected patients on suppressive antiretroviral therapy. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto